Internal body clocks, vital for sleep & health, are linked to DNA repair. Research shows a protein, 6–4phr, manages both DNA ...
Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease and offered meaningful results in DESTINY-Breast04. In a 2025 real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback